 10. Subjects with Stage III or Stage IV prostate cancers who have received and not responded to radiation therapy, surgery if applicable and hormonal therapy, and are hormone-refractory. Subjects must have two consecutive PSA values, at least 14 days apart, each 5 ngml and 50 above the minimum PSA observed during castration therapy or above the pretreatment value if there was no response. 